Medivir AB Statistics

Total Valuation

Medivir AB has a market cap or net worth of SEK 57.65 million. The enterprise value is 26.85 million.

Market Cap	57.65M
Enterprise Value	26.85M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Medivir AB has 112.17 million shares outstanding. The number of shares has increased by 28.57% in one year.

Current Share Class	112.17M
Shares Outstanding	112.17M
Shares Change (YoY)	+28.57%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.90%
Owned by Institutions (%)	33.35%
Float	85.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.47
PB Ratio	0.72
P/TBV Ratio	0.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.27
EV / Sales	6.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.70, with a Debt / Equity ratio of 0.09.

Current Ratio	0.70
Quick Ratio	0.70
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.32

Financial Efficiency

Return on equity (ROE) is -76.62% and return on invested capital (ROIC) is -45.48%.

Return on Equity (ROE)	-76.62%
Return on Assets (ROA)	-32.17%
Return on Invested Capital (ROIC)	-45.48%
Return on Capital Employed (ROCE)	-114.22%
Revenue Per Employee	398,400
Profits Per Employee	-9.79M
Employee Count	10
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.58% in the last 52 weeks. The beta is -0.19, so Medivir AB's price volatility has been lower than the market average.

Beta (5Y)	-0.19
52-Week Price Change	-80.58%
50-Day Moving Average	1.27
200-Day Moving Average	1.71
Relative Strength Index (RSI)	20.38
Average Volume (20 Days)	1,272,421

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medivir AB had revenue of SEK 3.98 million and -97.92 million in losses. Loss per share was -0.85.

Revenue	3.98M
Gross Profit	-69.49M
Operating Income	-99.37M
Pretax Income	-97.92M
Net Income	-97.92M
EBITDA	-99.24M
EBIT	-99.37M
Loss Per Share	-0.85

Full Income Statement

Balance Sheet

The company has 38.20 million in cash and 7.40 million in debt, giving a net cash position of 30.80 million or 0.27 per share.

Cash & Cash Equivalents	38.20M
Total Debt	7.40M
Net Cash	30.80M
Net Cash Per Share	0.27
Equity (Book Value)	79.60M
Book Value Per Share	0.71
Working Capital	-17.70M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-115.89M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,494.23%
Pretax Margin	-2,457.76%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medivir AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.57%
Shareholder Yield	-28.57%
Earnings Yield	-169.83%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medivir AB has an Altman Z-Score of -8.49. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.49
Piotroski F-Score	n/a